TempraMed inks distribution deal with CenterWell Pharmacy to expand US market reach

TempraMed Technologies Ltd., a company specializing in temperature-controlled medication storage, has signed a distribution agreement with CenterWell Pharmacy, a branch of Humana Inc., a major US health insurer. This deal aims to distribute TempraMed's products like VIVI Cap® and VIVI Epi® through CenterWell, potentially expanding TempraMed's presence in the US healthcare market. The agreement does not guarantee minimum orders and can be terminated with 60 days' notice, but it represents a significant step for TempraMed's commercial growth in the US. The company expects this partnership to help patients and healthcare providers better manage temperature-sensitive medications.

As of Sep 23, 2026 14:12 WIB, Humana Inc. (HUM) shares are priced at USD 378.73 with a slight 1-day increase of 0.19% on Pluang. The stock shows a market capitalization of $45.46 billion and an enterprise value of $52.81 billion. Despite the recent distribution deal involving TempraMed, Pluang order activity remains predominantly sell at 81%, highlighting cautious investor sentiment.